Conditions: Chemotherapy-Induced Peripheral Neuropathy
Keywords: Pain chemotherapy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 64
Healthy volunteers: no

Brief summary:
Prevention and treatment of the severity of symptoms of chemotherapy-induced peripheral neuropathy.

Detailed description:
This study was terminated on July 15, 2008. The results of an interim analysis showed that the conditional power to detect a difference in treatment groups was insufficient to warrant study continuation and therefore termination of the trial was recommended. The decision to terminate the trial was not based on safety concerns.

Arms:
arm 1: flexible dosing arm 2: None

Interventions: intervention 1: Pregabalin intervention 2: Placebo
Intervention descriptions: intervention 1: 150- 600 mg/day (double blind in divided doses) intervention 2: Placebo

Protocol document: